The relation of synaptic biomarkers with Aβ, tau, glial activation, and neurodegeneration in Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
The relation of synaptic biomarkers with Aβ, tau, glial activation, and neurodegeneration in Alzheimer’s disease ; volume:13 ; number:1 ; day:28 ; month:5 ; year:2024 ; pages:1-5 ; date:12.2024
Translational neurodegeneration ; 13, Heft 1 (28.5.2024), 1-5, 12.2024
- Urheber
-
Wang, Yi-Ting
Ashton, Nicholas J.
Servaes, Stijn
Nilsson, Johanna
Woo, Marcel S.
Pascoal, Tharick A.
Tissot, Cécile
Rahmouni, Nesrine
Therriault, Joseph
Lussier, Firoza
Chamoun, Mira
Gauthier, Serge
Brinkmalm, Ann
Zetterberg, Henrik
Blennow, Kaj
Rosa-Neto, Pedro
Benedet, Andréa L.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40035-024-00420-1
- URN
-
urn:nbn:de:101:1-2408060953511.376574591741
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:04 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wang, Yi-Ting
- Ashton, Nicholas J.
- Servaes, Stijn
- Nilsson, Johanna
- Woo, Marcel S.
- Pascoal, Tharick A.
- Tissot, Cécile
- Rahmouni, Nesrine
- Therriault, Joseph
- Lussier, Firoza
- Chamoun, Mira
- Gauthier, Serge
- Brinkmalm, Ann
- Zetterberg, Henrik
- Blennow, Kaj
- Rosa-Neto, Pedro
- Benedet, Andréa L.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
Heart fatty acid binding protein and Aβ-associated Alzheimer’s neurodegeneration
Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer’s disease, and neuronal injury in humans: a cohort study
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
Heart fatty acid binding protein and Aβ-associated Alzheimer’s neurodegeneration
Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer’s disease, and neuronal injury in humans: a cohort study
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
Heart fatty acid binding protein and Aβ-associated Alzheimer’s neurodegeneration